-
Gestational diabetes (gdm) now complicates about one in 15 pregnancies, but, undoubtedly, the prevalence will increase even further if we cannot curb the concerning rise in obesity in this country.
-
-
The authors assessed the risk of venous thrombosis (vt) in current users of non-oral hormonal contraception using four national registries in Denmark.
-
In this issue: Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.
-
Although the incidence of hysterectomy has declined in recent years, it remains the most common major gynecologic procedure, and many women are offered or consider elective bilateral oophorectomy (BSO) at the time of hysterectomy to reduce ovarian cancer risk.
-
Mediators of the autonomic response to stress, such as the catecholamines norepinephrine and epinephrine, promote cancer growth, metastasis, and progression in preclinical models.
-
Between September 1, 1987, and January 31, 2001, a total of 4047 obese persons were enrolled in the Swedish Obesity Study (SOS) intervention trial.
-
The emergence of maternal DNA testing for fetal an-euploidies has necessitated a rethinking of our standard screening protocols. With reasonable accuracy, a single blood test can now rule out fetal trisomy 21, 18, and 13, in addition to sex chromosome abnormalities such as Turner syndrome.
-
-
In this study, 4957 women aged 67 and older were followed prospectively for up to 15 years. Statistical models were used to calculate the bone mineral density (BMD) testing interval for women with normal BMD and those with mild, moderate, or advanced osteopenia.
